Navigation Links
Protalix BioTherapeutics Appoints Professor Roger D. Kornberg to Board of Directors
Date:2/12/2008

s and explore new biotherapeutic opportunities."

About Protalix BioTherapeutics, Inc.

Protalix is a biopharmaceutical company. Its goal is to become a fully integrated biopharmaceutical company focused on the development and commercialization of proprietary recombinant therapeutic proteins to be expressed through its proprietary plant cell based expression system. Protalix's ProCellEx(TM) presents a proprietary method for the expression of recombinant proteins that Protalix believes is safe and scalable and will allow for the cost-effective, industrial-scale production of recombinant therapeutic proteins. Protalix is enrolling and treating patients in its pivotal phase III clinical trial in Israel, the United States and other locations for its lead product candidate, prGCD, for its enzyme replacement therapy for Gaucher disease, a lysosomal storage disorder in humans, and has reached an agreement with the United States Food and Drug Administration on the final design of the pivotal phase III clinical trial through the FDA's Special Protocol Assessment (SPA) process. Protalix is also advancing additional recombinant biopharmaceutical drug development programs.

Safe Harbor Statement:

To the extent that statements in this press release are not strictly historical, all such statements are forward-looking, and are made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involve a high degree of risk. Factors that might cause such a material difference include, among others, uncertainties related to the ability to attract and retain partners for our technologies and products under development
'/>"/>

SOURCE Protalix BioTherapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Protalix BioTherapeutics Announces Resignation of Board Members
2. Protalix BioTherapeutics prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific
3. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
4. AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors
5. Natural Alternatives International, Inc. Appoints New Chief Financial Officer
6. Deerfield Spa Appoints New Fitness Director
7. Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer
8. P\S\L Group appoints Paul Barnes as Group President P\S\L Research
9. AtriCure Appoints Mark A. Collar to its Board of Directors
10. Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board
11. Milestone Scientific Appoints Dental Industry Veteran Scott Mahnken as New Director of Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Verndale is pleased to announce their recent ... list ranking the fastest-growing private companies in America. The ... yearly percentage revenue growth over a three-year period. For ... 5000 list where it ranked number 2,855. , As ... a wide range of digital marketing services including core ...
(Date:8/20/2014)... North Carolina (PRWEB) August 20, 2014 ... , findings from a University College London (UCL) study ... disagreed on what method of brushing teeth was the ... found that six different tooth-brushing techniques were frequently recommended, ... the Charlotte Center for Cosmetic Dentistry, experienced cosmetic ...
(Date:8/20/2014)... 20, 2014 Oxnard dentist ... the Anacapa Dental Art Institute, is presenting at the ... will be speaking on All-on-4 dental implants ... Graft Less Solutions” at 12:40 p.m. Sept. 20 at ... British Columbia, Canada. , “The All-on-4 procedure gives patients ...
(Date:8/20/2014)... 20, 2014 Biosimilars, which are ... approved through an abbreviated process, could reap billions ... Atlantic Information Services, Inc.’s (AIS) Specialty Pharmacy News ... including the Food and Drug Administration’s (FDA) recent ... towards approval. , Drugmaker Sandoz said July 24 ...
(Date:8/20/2014)... 20, 2014 No matter how “lonely” a ... a steady set of friends to be always there for ... to the concept of making new friends during adulthood ... ranging from taking care of one’s family to a near-slavish ... to a new person just is not the same as ...
Breaking Medicine News(10 mins):Health News:For the 8th Time, Verndale Has Been Honored on the Inc. 5000 List 2Health News:Ending Confusion About the Best Way to Brush Teeth 2Health News:Ending Confusion About the Best Way to Brush Teeth 3Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 2Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 3Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 2Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 3Health News:‘How to Make Friends as an Adult by Just Being Yourself: Becoming a “People Person” In Three Steps or Less’ Gives Tips for Making Friends During Adulthood - Vinamy 2
... the psychiatrist Dr Charles Reynolds at the University of Pittsburgh ... , The study’s main aim was to analyze ... elderly people. It is one of the longest studies ... prescribe antidepressants for longer periods, perhaps even for life, in ...
... Department of New South Wales has conducted a study which ... the user's physical health// . , It is ... Cannabis abuse can lead to cardiovascular, respiratory and immune system ... slow brain development at a young age. New South Wales ...
... Yale shed new light on the mechanism of nerve ... "motor" protein, myosin-II, according to an //article in the ... develop or attempt to recover after damage, they extend ... sensors. Growth cones use the information they gather to ...
... shorts in football prints and innerwear with net inserts ... lingerie designers are experimenting with.,Overall, the trend in lingerie ... with a hint of romance. The seductive undergarments require ... being tried with embroidery. The garments aren't so opulent, ...
... overcrowding of farm owners in local veterinary centres has created much ... Nadub //. The deadly avian influenza virus outbreak in India was ... 20 chickens dropped dead Saturday in Manakkad area of Salem district, ... for tests. ,Tamil Nadu has been on high alert ...
... pain by taking Oxycontin, a prescription painkiller. Later on for ... cheaper option. // Michaud, now 18 years is one ... prescription drugs. Teenagers are increasingly experimenting with legal drugs like ... from medicine cabinets. , Health officials say that ...
Cached Medicine News:Health News:Drugs Are Effective In Treating Depression and Preventing Recurrence 2Health News:A New Focus For The Mechanism Of Nerve Growth 2Health News:Romantic and discreet trends in lingerie 2Health News:New Generation Teenagers Addiction to Prescription Drugs 2
(Date:8/20/2014)... , Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces ... Ltd., has received Chinese FDA (CFDA) approval and ... Tablets into the China ... and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., ... US FDA approved and China CFDA certified oral ...
(Date:8/20/2014)... 20, 2014   Easy Breathe , the fastest growing online ... Easy Blog " - has received more than 4.5 million unique ... "We are thrilled that so many people are finding our blog ... Easy Breathe. "We,re committed to making sleep apnea more widely known ... informed about sleep apnea news , troubleshooting advice , ...
(Date:8/20/2014)... , August 20, 2014 ... subsidiary of Glenmark Pharmaceuticals Limited India (GPL), announces ... of a novel clinical development candidate, GBR 1302, ... and developed by the Glenmark Biologics Research Centre ... . GBR 1302 is based on Glenmark,s innovative ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3
... SAN DIEGO, May 16, 2011 Cardium Therapeutics ... its financial results for the first quarter ended ... ) (Logo:   http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO ) ... quarter 2011 financial results, Cardium reported on the ...
... R.I., May 16, 2011 Obtaining prior authorization for ... and pharmacists that currently requires phone calls, faxes and ... they do not provide both a real-time solution and ... health record (EHR) tools.  Recognizing this gap in the ...
Cached Medicine Technology:Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 2Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 3Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 4Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 5Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 6Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 7Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 8Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 9Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 10CVS Caremark to Pilot Electronic Prior Authorization to Help Speed Patient Access to Prescription Medication 2CVS Caremark to Pilot Electronic Prior Authorization to Help Speed Patient Access to Prescription Medication 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: